| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-06 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-05 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-05 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.002 |